Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004648385 | SCV005153377 | pathogenic | Inborn genetic diseases | 2024-06-12 | criteria provided, single submitter | clinical testing | The c.6331G>T (p.E2111*) alteration, located in exon 15 (coding exon 15) of the PKD1 gene, consists of a G to T substitution at nucleotide position 6331. This changes the amino acid from a glutamic acid (E) to a stop codon at amino acid position 2111. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. |
Fulgent Genetics, |
RCV005015228 | SCV005641323 | likely pathogenic | Polycystic kidney disease, adult type | 2024-02-10 | criteria provided, single submitter | clinical testing |